Capital formation challenges in the industry have forced many biotech companies to halt projects, lay off staff or shutdown all together. Our analysis shows that the industry is approximately one-quarter smaller than it was in 2008.
|
February 5, 2010
|
February 2, 2010
|
January 28, 2010
|
January 20, 2010
|
|
January 12, 2010
|
December 17, 2009
|
December 15, 2009
|
December 8, 2009
|